Forum Klix.ba

Naslovnica wrote: ↑21/09/2021 10:31

TheHound wrote: ↑21/09/2021 10:29

Kad su ih primili 10 ne vidim problem da prime i 11-tu vakcinu.

LogiĆno.

TheHound wrote: ↑21/09/2021 10:44

Naslovnica wrote: ↑21/09/2021 10:31

LogiĆno.

Pa da. Ne znam sastav ni onih MMR i ostalih koje su do sad primili, ako ce im ova pomoc kao sto im te pomazu eto nas u Zetru.

Naslovnica wrote: ↑21/09/2021 10:46

TheHound wrote: ↑21/09/2021 10:44

Pa da. Ne znam sastav ni onih MMR i ostalih koje su do sad primili, ako ce im ova pomoc kao sto im te pomazu eto nas u Zetru.

Ako će im pomoći u vezi čega konkretno?

TheHound wrote: ↑21/09/2021 10:49

Naslovnica wrote: ↑21/09/2021 10:46

Ako će im pomoći u vezi čega konkretno?

Cisto da vidim s kim razgovaram. Sta mislis u vezi cega pomaze vakcina protiv korona virusa nama odraslima?

Naslovnica wrote: ↑21/09/2021 10:54

TheHound wrote: ↑21/09/2021 10:49

Cisto da vidim s kim razgovaram. Sta mislis u vezi cega pomaze vakcina protiv korona virusa nama odraslima?

Ja te fino upitah nešto, nisi mi ništa odgovorio, i očekuješ da ja tebi dam odgovor?

TheHound wrote: ↑21/09/2021 11:06

Naslovnica wrote: ↑21/09/2021 10:54

Ja te fino upitah nešto, nisi mi ništa odgovorio, i očekuješ da ja tebi dam odgovor?

Ne moras. Ja sam pitao da vidim s kim razgovaram, da ne gubim vrijeme na antivaksere.

Naslovnica wrote: ↑21/09/2021 11:15

TheHound wrote: ↑21/09/2021 11:06

Ne moras. Ja sam pitao da vidim s kim razgovaram, da ne gubim vrijeme na antivaksere.

Nisam antivakser.

Naslovnica wrote: ↑21/09/2021 11:15

TheHound wrote: ↑21/09/2021 11:06

Ne moras. Ja sam pitao da vidim s kim razgovaram, da ne gubim vrijeme na antivaksere.

Nisam antivakser.

laik1981 wrote: ↑21/09/2021 11:19

Naslovnica wrote: ↑21/09/2021 11:15

Nisam antivakser.

To je diskutabilno.. Nema veze sto si se ti vakcinisao.. Ako imas kakvu dilemu u vezi vakcinisanja svoje djece opet si antivakser

TheHound wrote: ↑21/09/2021 11:20

Naslovnica wrote: ↑21/09/2021 11:15

Nisam antivakser.

Pa onda ti je jasno koliko i meni sta je vakcina i cemu sluzi, nema potreba da ti objasnjavam a nisam ni neki strucnjak.

BadBoy wrote: ↑21/09/2021 08:00

Mislim da je to naša budućnost: svi ćemo se zaraziti i/ili vakcinisati. Vakcinisani će tu zarazu prebroditi onako s nogu i pri tome će boostat imunitet, nevakcinisani će imati random ishod i tako će se ovo sve pretvoriti u sezonsku virozu.

Do pojave nekog novog soja

Naslovnica wrote: ↑21/09/2021 11:21

laik1981 wrote: ↑21/09/2021 11:19
To je diskutabilno.. Nema veze sto si se ti vakcinisao.. Ako imas kakvu dilemu u vezi vakcinisanja svoje djece opet si antivakser

Pa nemam nikakvu dilemu, samo pitam u čemu će to Pfizer vakcina konkretno pomoći djeci, da ih i ja odvedem na Zetru i vakcinišem čim se otvori mogućnost.

laik1981 wrote: ↑21/09/2021 11:24

Naslovnica wrote: ↑21/09/2021 11:21
Pa nemam nikakvu dilemu, samo pitam u čemu će to Pfizer vakcina konkretno pomoći djeci, da ih i ja odvedem na Zetru i vakcinišem čim se otvori mogućnost.

Pa vidis da imas dilemu..

Naslovnica wrote: ↑21/09/2021 11:21

laik1981 wrote: ↑21/09/2021 11:19
To je diskutabilno.. Nema veze sto si se ti vakcinisao.. Ako imas kakvu dilemu u vezi vakcinisanja svoje djece opet si antivakser

Pa nemam nikakvu dilemu, samo pitam u čemu će to Pfizer vakcina konkretno pomoći djeci, da ih i ja odvedem na Zetru i vakcinišem čim se otvori mogućnost.

KraljicaIzJajca wrote: ↑21/09/2021 11:34

Naslovnica wrote: ↑21/09/2021 11:21
Pa nemam nikakvu dilemu, samo pitam u čemu će to Pfizer vakcina konkretno pomoći djeci, da ih i ja odvedem na Zetru i vakcinišem čim se otvori mogućnost.

Što pišu o tome virolozi? Rezultati istraživanja cjepiva na maloljetnicima?

Naslovnica wrote: ↑21/09/2021 11:44

KraljicaIzJajca wrote: ↑21/09/2021 11:34

Što pišu o tome virolozi? Rezultati istraživanja cjepiva na maloljetnicima?

Prema Pfizeru, vakcina je sigurna za djecu 05-12.
Ali ja čitam mnogo oprečnih stavova struke, jedni su za vakcinaciju dječurlije, drugi nisu izričito, a moji su i preboljeli prošle godine, tako da ne može čovjek biti pametan.
Nismo ih nikada vakcinisali protiv sezonske gripe, mada je preporuka da se vakcinišu svake godine, od 6 mjeseci pa na dalje. Da li smo zbog toga antivakseri, ili smo samo primitivni balkanci, ništa mi više nije jasno.
Ne bih želio da nana nepokretna nana u ljetnjoj kuhinji preseli zato što su joj unuci prenijeli COVID-19 (iako je vakcinisana, spava sa maskom i pazi se), ali ne bih da rizikujem.
Baš ne zna čovjek koga bi slušao.

KraljicaIzJajca wrote: ↑21/09/2021 12:08

Naslovnica wrote: ↑21/09/2021 11:44

Prema Pfizeru, vakcina je sigurna za djecu 05-12.
Ali ja čitam mnogo oprečnih stavova struke, jedni su za vakcinaciju dječurlije, drugi nisu izričito, a moji su i preboljeli prošle godine, tako da ne može čovjek biti pametan.
Nismo ih nikada vakcinisali protiv sezonske gripe, mada je preporuka da se vakcinišu svake godine, od 6 mjeseci pa na dalje. Da li smo zbog toga antivakseri, ili smo samo primitivni balkanci, ništa mi više nije jasno.
Ne bih želio da nana nepokretna nana u ljetnjoj kuhinji preseli zato što su joj unuci prenijeli COVID-19 (iako je vakcinisana, spava sa maskom i pazi se), ali ne bih da rizikujem.
Baš ne zna čovjek koga bi slušao.

Pfizer je testirao djecu? Gdje su rezultati testiranja?

Cjepiva za sezonsku gripu su neuporediva sa ovim cjepivom.

Razumijem, nezgodna situacija, možda povremeno koristiti kučne antigen testove.

Naslovnica wrote: ↑21/09/2021 12:14

KraljicaIzJajca wrote: ↑21/09/2021 12:08

Pfizer je testirao djecu? Gdje su rezultati testiranja?

Cjepiva za sezonsku gripu su neuporediva sa ovim cjepivom.

Razumijem, nezgodna situacija, možda povremeno koristiti kučne antigen testove.

https://edition.cnn.com/2021/09/20/heal ... index.html

Covid-19 vaccine for 5- to 11-year-olds is safe and shows 'robust' antibody response, Pfizer says

KraljicaIzJajca wrote: ↑21/09/2021 13:19

Naslovnica wrote: ↑21/09/2021 12:14

https://edition.cnn.com/2021/09/20/heal ... index.html

Covid-19 vaccine for 5- to 11-year-olds is safe and shows 'robust' antibody response, Pfizer says

These are the first such results released for this age group for a US Covid-19 vaccine, and the data has not yet been peer-reviewed or published. Pfizer said it plans to submit to the US Food and Drug Administration for emergency use authorization soon. FDA officials have said that once data is submitted, the agency could authorize a vaccine for younger children in a matter of weeks.

Još nije odobreno.

Naslovnica wrote: ↑21/09/2021 13:30

KraljicaIzJajca wrote: ↑21/09/2021 13:19

These are the first such results released for this age group for a US Covid-19 vaccine, and the data has not yet been peer-reviewed or published. Pfizer said it plans to submit to the US Food and Drug Administration for emergency use authorization soon. FDA officials have said that once data is submitted, the agency could authorize a vaccine for younger children in a matter of weeks.

Još nije odobreno.

Pa trolam ba, ne interesuju me COVID vakcine za klince.

jagugu wrote: ↑22/09/2021 00:46 Imal' kakvih novosti što se tiče priznavanja kineske vakcine u EU? Mislim znam da je priznata u nekim zemljama EU ali u većini nije. Nešto kontam koliko se dunjaluka vakcinisalo kineskom, valjda nekad i taj zapad popusti?

Ja sam također vakcinisan kinezom i nemali broj ljudi kojim sam rekao da sam primio SInopharm pogleda me ko luđaka koji je uzeo heroin jer ipak nije "fensi" poput pfizera i naravno obavezno prvo pitanje s gađenjem bude "Jao pa što nju uze, ne možeš niđe putovat".

Covid-19: Study that claimed boys are at increased risk of myocarditis after vaccination is deeply flawed, say critics

The risk of 12-15 year old healthy boys experiencing cardiac adverse events such as myocarditis after their second dose of the Pfizer and BioNTech vaccine is around four times adolescents’ risk of being admitted to hospital as a result of infection with SARS-CoV-2, a preprint study has found.1

However, the study has been widely criticised for mining data from an inappropriate source to deliver an antivaccine message, despite warnings against such data uses.

The retrospective study, which has not yet been peer reviewed, used the US vaccine adverse reporting system (VAERS) to identify the rate of post-vaccination myocarditis among 12-15 and 16-17 year olds between January and June 2021 after the second dose of the Pfizer-BioNTech vaccine. The researchers concluded that the rate of cardiac adverse events after the second dose exceeded the expected rate of 120 day covid-19 hospital admission at both a moderate (August 2021) and a high (January 2021) incidence of SARS-CoV-2 infection.

They estimated that the rate of cardiac myocarditis after the second dose of the vaccine was 162.2 cases per million in healthy boys aged 12-15 years and 94.0 per million in those aged 16-17. For klix the rate was 13 per million in 12-15 year olds and 13.4 per million in 16-17 year olds. Nearly all (86%) of the boys affected needed some form of hospital care, the authors said. By comparison, at current infection rates the risk of a healthy adolescent being admitted to hospital within 120 days of infection in the US is estimated to be 44 per million.

Trish Greenhalgh, professor of primary care health sciences at the University of Oxford, told The BMJ that although all preprints were suspect before they were peer reviewed, some were more suspect than others.

She said, “The VAERS database is a passive monitoring system maintained by the US Food and Drug Administration and Centers for Disease Control and Prevention that invites the public to report any perceived or suspected side effects following vaccination, so that potential signals of harm may be investigated further. Crucially, all such reports must be validated by other active monitoring systems, as VAERS entries are very prone to reporting and recall bias.

“Indeed, the CDC explicitly states that VAERS cannot be used in isolation to infer the existence, frequency, or rates of vaccine complications.”

Greenhalgh said that although the FDA and CDC used VAERS data to generate hypothesis driven questions about effects of covid vaccines in teenagers, the agencies then investigated before concluding that these vaccines were safe.

“VAERS data dredging, as it is known, has been used by antivaccine groups in the past to produce alarmist estimates of harms from vaccines,” she said.

In a blog post on the website Science-Based Medicine, Dan Freedman, a paediatric neurologist in Austin, Texas, highlighted this and other methodological flaws of the study, including that many of the “cases” of myocarditis may have been from an infection or another diagnosis altogether.2 He described the analysis as “half-baked” with “data that will certainly be co-opted by the antivaccine movement.”

The US and Israel have been among the first countries to widely vaccinate younger people and so preliminary data on vaccine complications in these groups are becoming more readily available.

A large Israeli study published in the New England Journal of Medicine showed an excess risk of myocarditis in people over 16 receiving the Pfizer-BioNTech vaccine (1-5 events per 100 000 persons).3 While demographic information was not specifically analysed, it was notable that 19 of the 21 myocarditis cases were in males, with the median age of those affected being 25.

In June the US Centers for Disease Control and Prevention’s safety committee said there was a “likely association” between the Pfizer-BioNTech and Moderna covid vaccines and myocarditis and pericarditis in some young adults, but the US Department of Health and Human Services and other agencies emphasised that the side effect was “extremely rare” and that most cases were mild.4

The UK’s Medicines and Healthcare Products Regulatory Agency said it had come to the same conclusions: cases of myocarditis and pericarditis were rare and tended to be mild, with most affected people recovering with simple treatment and rest.

The study’s authors defended their use of the VAERS database and their selection of cases. Coauthor Allison Krug told The BMJ, “Because VAERS is a national surveillance system with a simple reporting mechanism, it yields timely information and has high sensitivity for new vaccine safety concerns.”

Coauthor Tracy Beth Høeg added, “We went through all entries to ensure there was objective evidence of cardiac damage and that these were not self-reports of just ‘chest pain’ but required the same objective evidence of cardiac injury that the CDC did in their analysis.”

Krug said that as they revised their study the team would be looking at comparing rates of hospital admission for myocarditis with admission rates for covid infection.

https://www.bmj.com/content/374/bmj.n2251